Majdi and colleagues (9) reported that concentrations of RIP1 and MLKL were increased in serum of patients with NASH in patients with activity score greater than or equal to 2 compared with those with activity score less than 2. The gene discussed is MLKL; the disease is metabolic dysfunction-associated steatohepatitis.